Skip to main content
Log in

Enhancing cellular immune response to HBV M DNA vaccine in mice by codelivery of interleukin-18 recombinant

  • Biomedical Science
  • Published:
Journal of Zhejiang University-SCIENCE A Aims and scope Submit manuscript

Abstract

Objective: To investigate the effect of interleukin-18 (IL-18) on immune response induced by plasmid encoding hepatitis B virus middle protein antigen and to explore new strategies for prophylactic and therapeutic HBV DNA vaccines. Methods: BALB/c mice were immunized with pCMV-M alone or co-immunized with pcDNA3–18 and pCMV-M and then their sera were collected for analysing anti-HBsAg antibody by ELISA; splenocytes were isolated for detecting specific CTL response and cytokine assayin vitro. Results: The anti-HBs antibody level of mice co-immunized with pcDNA3–18 and pCMV-M was slightly higher than that of mice immunized with pCMV-M alone, but there was not significantly different (P>0.05). Compared with mice injected with pCMV-M, the specific CTL cytotoxity activity of mice immunized with pcDNA3–18 and pCMV-M was significantly enhanced (P<0.05) and the level of IFN-γ in supernatant of splenocytes cultured with HBsAgin vitro was significantly elevated (P<0.05) while the level of IL-4 had no significant difference (P>0.05). Conclusion: The plasmid encoding IL-18 together with HBV M gene DNA vaccines may enhance specific TH1 cells and CTL cellular immune response induced in mice, so that IL-18 is a promising immune adjuvant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Babiuk, L.A., Babiul, S.L., Baca-Estrada, M.E., 2002. Novel vaccine strategies.Adv Virus Res,58:29–80.

    Article  Google Scholar 

  • Beckebaum, S., Cicinnati, V.R., Gerken, G., 2002. DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?Rev Med Virol,12(5):297–319.

    Article  Google Scholar 

  • Biet, F., Locht, C., Kremer, L., 2002. Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens.J Mol Med,80(3):147–162.

    Article  Google Scholar 

  • Chen, J.Z., Zhu, H.H., Liu, K.Z., Chen, Z., 2002. Immuneresponse induced in mice by codelivery of IL-18 recombinant and HBV S gene DNA vaccine.Chin J Infect Dis,20(3):156–158 (in Chinese).

    Google Scholar 

  • Chisari, F.V., Ferrari, C., 1995. Hepatitis B virus immunopathogenesis.Annu Rev Immunol,13:29–60.

    Article  Google Scholar 

  • Chow, Y.H., Huang, W.L., Chi, W.K., Chu, Y.D., Tao, M.H., 1997. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.J Virol,71(1):169–178.

    Article  Google Scholar 

  • Chow, Y.H., Chiang, B.L., Lee, Y.L., Chi, W.K., Lin, W.C., Chen, Y.T., Tao, M.H., 1998. Development of Th1 and Th2 populations and the nature of immune response to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.J Immunol,160(3):1320–1329.

    Article  Google Scholar 

  • Davis, H.L., Mancini, M., Michel, M.L., Whalen, R.G., 1996. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.Vaccine,14(9):910–915.

    Article  Google Scholar 

  • Franco, A., Guidotti, L.G., Hobbs, M.V., Pasquetto, V., Chisari, F.V., 1997. Pathogenic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice.J Immunol,159(4):2001–2008.

    Article  Google Scholar 

  • Geissler, M., Tokushige, K., Chante, C.C., Zurawski, V.R. Jr., Wands, J.R., 1997. Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization.Gastroenterology,112(4):1307–1320.

    Article  Google Scholar 

  • Geissler, M., Schirmbeck, R., Reimann, J., Blum, H.E., Wands, J.R., 1998. Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle and but not the large hepatitis B virus surface antigen in mice.Hepatology,28(1):202–210.

    Article  Google Scholar 

  • Guidotti, L.G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., Chisari, F.V., 1999. Viral clearance without destruction of infected cells during acute HBV infection.Science,284(5415):825–829.

    Article  Google Scholar 

  • Jung, M.C., Hartmann, B., Gerlach, J.T., Diepolder, H., Gruber, R., Schraut, W., Gruner, N., Zachoval, R., Hoffmann, R., Santantonio, T., Wachtler, M., Pape, G.R., 1999. Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection.Virology,261(2):165–172.

    Article  Google Scholar 

  • Krieg, A.M., Davis, H.L., 2001. Enhancing vaccines with immune stimulatory CpG DNA.Curr Opin Mol Ther,3(1):15–24.

    Google Scholar 

  • Leroux-Roels, G., Van, Hecke, E., Michielsen, W., Voet, P., Hauser, P., Petre, J., 1994. Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.Vaccine,12(9):812–818.

    Article  Google Scholar 

  • Livingston, B.D., Alexander, J., Crimi, C., Oseroff, C., Celis, E., Daly, K., Guidotti, L.G., Chisari, F.V., Fikes, J., Chesnut, R.W., Sette, A., 1999. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans.J. Immunol,162(5):3088–3095.

    Article  Google Scholar 

  • Mancini, M., Hadchouel, M., Davis, H.L., Whalen, R.G., Tiollais, P., Michel, M.L., 1996. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state.Proc Natl Acad Sci USA,93(22):12496–12501.

    Article  Google Scholar 

  • Nakanishi, K., Yoshimoto, T., Tsutsui, H., Okamura, H., 2001. Interleukin-18 regulates both Th1 and Th2 responses.Annu Rev Immunol,19:423–474.

    Article  Google Scholar 

  • Oka, Y., Akbar, S.M., Horrike, N., Joko, K., Onji, M., 2001. Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice.Immunology,103(1):90–97.

    Article  Google Scholar 

  • Rehermann, B., Fowler, P., Sidney, J., Person, J., Redeker, A., Brown, M., Moss, B., Sette, A., Chisari, F.V., 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.J Exp Med,181(3):1047–1058.

    Article  Google Scholar 

  • Rehermann, B., Lau, D., Hoofnagle, J.H., Chisari, F.V., 1996. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.J Clin Invest,97(7):1655–1665.

    Article  Google Scholar 

  • Tang, D.C., DeVit, M., Johnston, S.A., 1992. Genetic immunization is a simple method for cliciting an immune response.Nature,356(6365):152–154.

    Article  Google Scholar 

  • Wolff, J.A., Malone, R.W., Williams, P., Chong, W., Acsadi, G., Jani, A., Felgner, P.L., 1990. Direct gene transfer into mouse muscle in vivo.Science,247(4949 Pt 1): 1465–1468.

    Article  Google Scholar 

  • Wolff, J.A., Ludtke, J.J., Acsadi, G., Williams, P., Jani, A., 1992. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle.Hum Mol Genet,1(6):363–369.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chen Jian-zhong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, Jz., Zhu, Hh., Liu, Kz. et al. Enhancing cellular immune response to HBV M DNA vaccine in mice by codelivery of interleukin-18 recombinant. J. Zheijang Univ.-Sci. 5, 467–471 (2004). https://doi.org/10.1631/jzus.2004.0467

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1631/jzus.2004.0467

Key words

Document code

CLC number

Navigation